
Shanon A. Foley
Examiner (ID: 19153, Phone: (571)272-0898 , Office: P/1648 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1619, 1642, 1648, 1671, 1645 |
| Total Applications | 1526 |
| Issued Applications | 841 |
| Pending Applications | 339 |
| Abandoned Applications | 367 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16569216
[patent_doc_number] => 20210008222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => PLANT VIRUS PARTICLES FOR DELIVERY OF ANTIMITOTIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/030793
[patent_app_country] => US
[patent_app_date] => 2020-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9211
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17030793
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/030793 | Plant virus particles for delivery of antimitotic agents | Sep 23, 2020 | Issued |
Array
(
[id] => 19338570
[patent_doc_number] => 12048741
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-30
[patent_title] => Recombinant host cell with heterologous nucleic acids encoding SHREK proteins
[patent_app_type] => utility
[patent_app_number] => 17/031082
[patent_app_country] => US
[patent_app_date] => 2020-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 18
[patent_no_of_words] => 11072
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17031082
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/031082 | Recombinant host cell with heterologous nucleic acids encoding SHREK proteins | Sep 23, 2020 | Issued |
Array
(
[id] => 17865452
[patent_doc_number] => 20220288187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => BIODEGRADABLE NANOCOMPLEX VACCINES, METHODS FOR SUPPRESSION OF HEPAPITIS B VIRUS REPLICATION AND HEPAPITIS B VIRUS SURFACE ANTIGEN SECRETION
[patent_app_type] => utility
[patent_app_number] => 17/763184
[patent_app_country] => US
[patent_app_date] => 2020-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5271
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17763184
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/763184 | BIODEGRADABLE NANOCOMPLEX VACCINES, METHODS FOR SUPPRESSION OF HEPAPITIS B VIRUS REPLICATION AND HEPAPITIS B VIRUS SURFACE ANTIGEN SECRETION | Sep 22, 2020 | Abandoned |
Array
(
[id] => 19225483
[patent_doc_number] => 12005113
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-11
[patent_title] => Porcine epidemic diarrhea virus strains and immunogenic compositions therefrom
[patent_app_type] => utility
[patent_app_number] => 17/021261
[patent_app_country] => US
[patent_app_date] => 2020-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 198
[patent_figures_cnt] => 236
[patent_no_of_words] => 40575
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17021261
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/021261 | Porcine epidemic diarrhea virus strains and immunogenic compositions therefrom | Sep 14, 2020 | Issued |
Array
(
[id] => 17921628
[patent_doc_number] => 11464849
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-11
[patent_title] => Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/017342
[patent_app_country] => US
[patent_app_date] => 2020-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 50
[patent_no_of_words] => 40258
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17017342
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/017342 | Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof | Sep 9, 2020 | Issued |
Array
(
[id] => 16989387
[patent_doc_number] => 20210227807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => METHOD FOR DETECTION AND MITIGATION OF COMPOUND PRODUCING MICROBIOTA IN AN AQUACULTURE SYSTEM
[patent_app_type] => utility
[patent_app_number] => 16/992760
[patent_app_country] => US
[patent_app_date] => 2020-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13289
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16992760
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/992760 | METHOD FOR DETECTION AND MITIGATION OF COMPOUND PRODUCING MICROBIOTA IN AN AQUACULTURE SYSTEM | Aug 12, 2020 | Abandoned |
Array
(
[id] => 18064479
[patent_doc_number] => 20220395566
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => IMMUNOGENIC COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/634272
[patent_app_country] => US
[patent_app_date] => 2020-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34956
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17634272
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/634272 | IMMUNOGENIC COMPOSITION | Aug 9, 2020 | Abandoned |
Array
(
[id] => 16915858
[patent_doc_number] => 20210188950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => Antibodies Against F Glycoprotein of Hendra and Nipah Viruses
[patent_app_type] => utility
[patent_app_number] => 16/988835
[patent_app_country] => US
[patent_app_date] => 2020-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16831
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16988835
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/988835 | Antibodies against F glycoprotein of Hendra and Nipah viruses | Aug 9, 2020 | Issued |
Array
(
[id] => 17836487
[patent_doc_number] => 20220273792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => A METHOD OF ELICITING AN IMMUNE RESPONSE BY ADMINISTERING A POPULATION OF POLYMERSOMES HAVING AN ASSOCIATED ANTIGEN TOGETHER WITH A POPULATION OF POLYMERSOMES HAVING AN ASSOCIATED ADJUVANT AS WELL AS COMPOSITIONS COMPRISING THE TWO POPULATIONS OF POLYMERSOMES
[patent_app_type] => utility
[patent_app_number] => 17/631845
[patent_app_country] => US
[patent_app_date] => 2020-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56089
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17631845
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/631845 | A METHOD OF ELICITING AN IMMUNE RESPONSE BY ADMINISTERING A POPULATION OF POLYMERSOMES HAVING AN ASSOCIATED ANTIGEN TOGETHER WITH A POPULATION OF POLYMERSOMES HAVING AN ASSOCIATED ADJUVANT AS WELL AS COMPOSITIONS COMPRISING THE TWO POPULATIONS OF POLYMERSOMES | Aug 2, 2020 | Pending |
Array
(
[id] => 16697899
[patent_doc_number] => 10948490
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-03-16
[patent_title] => Severe acute respiratory syndrome (SARS)--associated coronavirus diagnostics
[patent_app_type] => utility
[patent_app_number] => 16/944649
[patent_app_country] => US
[patent_app_date] => 2020-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 18
[patent_no_of_words] => 11387
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16944649
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/944649 | Severe acute respiratory syndrome (SARS)--associated coronavirus diagnostics | Jul 30, 2020 | Issued |
Array
(
[id] => 18732575
[patent_doc_number] => 11801295
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-31
[patent_title] => Immunogenic compositions and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/941481
[patent_app_country] => US
[patent_app_date] => 2020-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 55
[patent_no_of_words] => 31740
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16941481
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/941481 | Immunogenic compositions and uses thereof | Jul 27, 2020 | Issued |
Array
(
[id] => 17828504
[patent_doc_number] => 20220265808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => A PORCINE CIRCOVIRUS TYPE 2 (PCV2) VACCINE
[patent_app_type] => utility
[patent_app_number] => 17/628403
[patent_app_country] => US
[patent_app_date] => 2020-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14984
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17628403
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/628403 | A PORCINE CIRCOVIRUS TYPE 2 (PCV2) VACCINE | Jul 26, 2020 | Abandoned |
Array
(
[id] => 17355429
[patent_doc_number] => 20220016225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => VACCINE COMPOSITIONS AND ADJUVANT
[patent_app_type] => utility
[patent_app_number] => 16/933157
[patent_app_country] => US
[patent_app_date] => 2020-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9309
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16933157
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/933157 | VACCINE COMPOSITIONS AND ADJUVANT | Jul 19, 2020 | Abandoned |
Array
(
[id] => 18418586
[patent_doc_number] => 20230173044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => RECOMBINANT PROTEIN FOR REMOVING BOAR TAINT AND VACCINE COMPOSITION COMPRISING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/964632
[patent_app_country] => US
[patent_app_date] => 2020-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7675
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16964632
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/964632 | RECOMBINANT PROTEIN FOR REMOVING BOAR TAINT AND VACCINE COMPOSITION COMPRISING THE SAME | Jun 28, 2020 | Abandoned |
Array
(
[id] => 17881220
[patent_doc_number] => 20220296697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => PORCINE CIRCOVIRUS TYPE 2 VLP VACCINE
[patent_app_type] => utility
[patent_app_number] => 17/634488
[patent_app_country] => US
[patent_app_date] => 2020-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9901
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17634488
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/634488 | Porcine circovirus type 2 VLP vaccine | Jun 22, 2020 | Issued |
Array
(
[id] => 17297932
[patent_doc_number] => 20210393771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => VIRAL VACCINES FOR IN VIVO EXPRESSION OF A NUCLEIC ACIDS ENCODIND AN IMMUNOGENIC PEPTIDE AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/909311
[patent_app_country] => US
[patent_app_date] => 2020-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15603
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16909311
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/909311 | Viral vaccines for in vivo expression of a nucleic acid encoding an immunogenic peptide and methods of using the same | Jun 22, 2020 | Issued |
Array
(
[id] => 16555719
[patent_doc_number] => 20210000867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => NEW ROUTE AND ENGINEERING PROTOCOLS FOR ALZHEIMERS DISEASE PREVENTION, TREATMENT AND NEURONAL REBUILDING
[patent_app_type] => utility
[patent_app_number] => 16/906450
[patent_app_country] => US
[patent_app_date] => 2020-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10806
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16906450
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/906450 | NEW ROUTE AND ENGINEERING PROTOCOLS FOR ALZHEIMERS DISEASE PREVENTION, TREATMENT AND NEURONAL REBUILDING | Jun 18, 2020 | Abandoned |
Array
(
[id] => 18700100
[patent_doc_number] => 11786587
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-17
[patent_title] => Composition of subunit dengue vaccine
[patent_app_type] => utility
[patent_app_number] => 16/906134
[patent_app_country] => US
[patent_app_date] => 2020-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 82
[patent_no_of_words] => 14150
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16906134
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/906134 | Composition of subunit dengue vaccine | Jun 18, 2020 | Issued |
Array
(
[id] => 17775058
[patent_doc_number] => 20220241407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => MINI-COMBINED ADJUVANTS CARRIER-FREE NANOPARTICLES AND REPARATION METHOD AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/256095
[patent_app_country] => US
[patent_app_date] => 2020-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2284
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17256095
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/256095 | MINI-COMBINED ADJUVANTS CARRIER-FREE NANOPARTICLES AND REPARATION METHOD AND APPLICATION THEREOF | Jun 16, 2020 | Abandoned |
Array
(
[id] => 17090919
[patent_doc_number] => 11119103
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-09-14
[patent_title] => Serological assays for SARS-CoV-2
[patent_app_type] => utility
[patent_app_number] => 16/900798
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15852
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16900798
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/900798 | Serological assays for SARS-CoV-2 | Jun 11, 2020 | Issued |